Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT06903442

Developing a Brief Intervention to Communicate Cardiovascular Risk to Patients Presenting to the Emergency Department With Chest Pain: a Co-Production Approach. Phase 2.

Led by University of Edinburgh · Updated on 2025-09-15

118

Participants Needed

1

Research Sites

26 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Some patients who come to the emergency department with chest pain and have not had a heart attack, are at an increased risk of having a heart attack in the future. The investigators know this by taking a blood test (troponin) which looks at damage to the patient's heart. These patients are often sent home from hospital with no information about their risk of heart disease. A patient survey revealed that patients in the emergency department would like to receive more information about heart disease. In this study the investigators will provide patients who are at increased risk of cardiovascular disease with their troponin value. The investigators will deliver this information within a cardiovascular brief intervention, which is a short conversation with a patient about their health. In a previous study the investigators carried out some interviews with patients to find out how their results should be delivered and what information should be included in a cardiovascular brief intervention. The investigators also asked them the best way to provide patients with this information. The aim of this part of the study it to determine if the new cardiovascular brief intervention helps patients understand their risk and if it results in them making changes to their health.

CONDITIONS

Official Title

Developing a Brief Intervention to Communicate Cardiovascular Risk to Patients Presenting to the Emergency Department With Chest Pain: a Co-Production Approach. Phase 2.

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients who present to the Emergency Department with symptoms suggestive of acute coronary syndrome
  • A maximum high-sensitivity cardiac troponin I between 5 ng/L and the sex-specific 99th centile
  • Resides in Scotland and has a CHI number
  • Adults aged 18 and over
  • No history of cardiovascular disease
  • At least 1 modifiable cardiovascular risk factor: current smoker, hypertension (140/90 mmHg), hypercholesterolaemia (>6.0 mmol/L), overweight and obesity (BMI >25), hyperglycaemia or diabetes mellitus
  • Patients who are able to provide informed consent
Not Eligible

You will not qualify if you...

  • Patients with a diagnosis of acute coronary syndrome during index presentation
  • Patients who are not able to give informed consent
  • Patients who do not speak English
  • Patients who are unable to attend hospital as outpatient to receive the cardiovascular brief intervention
  • Patients with ongoing or planned cardiovascular investigations or interventions
  • Patients with chronic kidney disease and a eGFR below 30 ml/min

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

NHS Lothian

Edinburgh, United Kingdom

Actively Recruiting

Loading map...

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

PREVENTION

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here